Back to User profile » Prof. Dr. Feng Gao

Papers published by Prof. Dr. Feng Gao:

Review

Theoretical overview of clinical and pharmacological aspects of the use of etelcalcetide in diabetic patients undergoing hemodialysis

Ye J, Deng G, Gao F

Drug Design, Development and Therapy 2018, 12:901-909

Published Date: 19 April 2018

Review

Clinical and pharmacological hallmarks of rifapentine’s use in diabetes patients with active and latent tuberculosis: do we know enough?

Zheng C, Hu X, Zhao L, Hu M, Gao F

Drug Design, Development and Therapy 2017, 11:2957-2968

Published Date: 11 October 2017

Review

Use of bedaquiline and delamanid in diabetes patients: clinical and pharmacological considerations

Hu MH, Zheng CL, Gao F

Drug Design, Development and Therapy 2016, 10:3983-3994

Published Date: 7 December 2016

Original Research

4-Hydroxyisoleucine ameliorates an insulin resistant-like state in 3T3-L1 adipocytes by regulating TACE/TIMP3 expression

Gao F, Du W, Zafar MI, Shafqat RA, Jian L, Cai Q, Lu FR

Drug Design, Development and Therapy 2015, 9:5727-5736

Published Date: 20 October 2015

Original Research

Effects of histamine and its antagonists on murine T-cells and bone marrow-derived dendritic cells

Hu XF, Zafar MI, Gao F

Drug Design, Development and Therapy 2015, 9:4847-4860

Published Date: 21 August 2015

Original Research

Effectiveness and safety of Humalog Mix 50/50 versus Humalog Mix 75/25 in Chinese patients with type 2 diabetes

Zafar MI, Ai X, Shafqat RA, Gao F

Therapeutics and Clinical Risk Management 2015, 11:27-32

Published Date: 19 December 2014